Click for best price
Vaccines For Children VFC Market Size, Share 2022
Market Analysis and Insights: Global Vaccines For Children VFC Market
The global Vaccines For Children VFC market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Vaccines For Children VFC market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Vaccines For Children VFC market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Vaccines For Children VFC market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Vaccines For Children VFC market.
Global Vaccines For Children VFC Scope and Market Size
Vaccines For Children (VFC) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Vaccines For Children (VFC) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Recombinant Vaccines
Viral Vaccines
Polysaccharide Vaccines
Others
Segment by Application
Government Institution
Private Sector
Other
By Company
GSK
Sanofi
Merck
Pfizer
Jintan
CSL
MedImmune LLC
J&J(Crucell)
China National Biotec
Tiantan
Hualan
Kangtai
Hissen
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Vaccines For Children VFC product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Vaccines For Children VFC, with price, sales, revenue, and global market share of Vaccines For Children VFC from 2019 to 2022.
Chapter 3, the Vaccines For Children VFC competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vaccines For Children VFC breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Vaccines For Children VFC market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Vaccines For Children VFC.
Chapter 13, 14, and 15, to describe Vaccines For Children VFC sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Vaccines For Children VFC Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global Vaccines For Children (VFC) Market Insights and Forecast to 2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
109 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Vaccines For Children (VFC) Product Introduction
1.2 Market by Type
1.2.1 Global Vaccines For Children (VFC) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Recombinant Vaccines
1.2.3 Viral Vaccines
1.2.4 Polysaccharide Vaccines
1.2.5 Others
1.3 Market by Application
1.3.1 Global Vaccines For Children (VFC) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Vaccines For Children (VFC) Sales Estimates and Forecasts 2017-2028
2.2 Global Vaccines For Children (VFC) Revenue Estimates and Forecasts 2017-2028
2.3 Global Vaccines For Children (VFC) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Vaccines For Children (VFC) Sales by Region
2.4.1 Global Vaccines For Children (VFC) Sales by Region (2017-2022)
2.4.2 Global Sales Vaccines For Children (VFC) by Region (2023-2028)
2.5 Global Vaccines For Children (VFC) Revenue by Region
2.5.1 Global Vaccines For Children (VFC) Revenue by Region (2017-2022)
2.5.2 Global Vaccines For Children (VFC) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Vaccines For Children (VFC) Sales by Manufacturers
3.1.1 Global Top Vaccines For Children (VFC) Manufacturers by Sales (2017-2022)
3.1.2 Global Vaccines For Children (VFC) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vaccines For Children (VFC) in 2021
3.2 Global Vaccines For Children (VFC) Revenue by Manufacturers
3.2.1 Global Vaccines For Children (VFC) Revenue by Manufacturers (2017-2022)
3.2.2 Global Vaccines For Children (VFC) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Vaccines For Children (VFC) Revenue in 2021
3.3 Global Vaccines For Children (VFC) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Vaccines For Children (VFC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Vaccines For Children (VFC) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Vaccines For Children (VFC) Sales by Type
4.1.1 Global Vaccines For Children (VFC) Historical Sales by Type (2017-2022)
4.1.2 Global Vaccines For Children (VFC) Forecasted Sales by Type (2023-2028)
4.1.3 Global Vaccines For Children (VFC) Sales Market Share by Type (2017-2028)
4.2 Global Vaccines For Children (VFC) Revenue by Type
4.2.1 Global Vaccines For Children (VFC) Historical Revenue by Type (2017-2022)
4.2.2 Global Vaccines For Children (VFC) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Vaccines For Children (VFC) Revenue Market Share by Type (2017-2028)
4.3 Global Vaccines For Children (VFC) Price by Type
4.3.1 Global Vaccines For Children (VFC) Price by Type (2017-2022)
4.3.2 Global Vaccines For Children (VFC) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Vaccines For Children (VFC) Sales by Application
5.1.1 Global Vaccines For Children (VFC) Historical Sales by Application (2017-2022)
5.1.2 Global Vaccines For Children (VFC) Forecasted Sales by Application (2023-2028)
5.1.3 Global Vaccines For Children (VFC) Sales Market Share by Application (2017-2028)
5.2 Global Vaccines For Children (VFC) Revenue by Application
5.2.1 Global Vaccines For Children (VFC) Historical Revenue by Application (2017-2022)
5.2.2 Global Vaccines For Children (VFC) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Vaccines For Children (VFC) Revenue Market Share by Application (2017-2028)
5.3 Global Vaccines For Children (VFC) Price by Application
5.3.1 Global Vaccines For Children (VFC) Price by Application (2017-2022)
5.3.2 Global Vaccines For Children (VFC) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Vaccines For Children (VFC) Market Size by Type
6.1.1 North America Vaccines For Children (VFC) Sales by Type (2017-2028)
6.1.2 North America Vaccines For Children (VFC) Revenue by Type (2017-2028)
6.2 North America Vaccines For Children (VFC) Market Size by Application
6.2.1 North America Vaccines For Children (VFC) Sales by Application (2017-2028)
6.2.2 North America Vaccines For Children (VFC) Revenue by Application (2017-2028)
6.3 North America Vaccines For Children (VFC) Market Size by Country
6.3.1 North America Vaccines For Children (VFC) Sales by Country (2017-2028)
6.3.2 North America Vaccines For Children (VFC) Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Vaccines For Children (VFC) Market Size by Type
7.1.1 Europe Vaccines For Children (VFC) Sales by Type (2017-2028)
7.1.2 Europe Vaccines For Children (VFC) Revenue by Type (2017-2028)
7.2 Europe Vaccines For Children (VFC) Market Size by Application
7.2.1 Europe Vaccines For Children (VFC) Sales by Application (2017-2028)
7.2.2 Europe Vaccines For Children (VFC) Revenue by Application (2017-2028)
7.3 Europe Vaccines For Children (VFC) Market Size by Country
7.3.1 Europe Vaccines For Children (VFC) Sales by Country (2017-2028)
7.3.2 Europe Vaccines For Children (VFC) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Vaccines For Children (VFC) Market Size by Type
8.1.1 Asia Pacific Vaccines For Children (VFC) Sales by Type (2017-2028)
8.1.2 Asia Pacific Vaccines For Children (VFC) Revenue by Type (2017-2028)
8.2 Asia Pacific Vaccines For Children (VFC) Market Size by Application
8.2.1 Asia Pacific Vaccines For Children (VFC) Sales by Application (2017-2028)
8.2.2 Asia Pacific Vaccines For Children (VFC) Revenue by Application (2017-2028)
8.3 Asia Pacific Vaccines For Children (VFC) Market Size by Region
8.3.1 Asia Pacific Vaccines For Children (VFC) Sales by Region (2017-2028)
8.3.2 Asia Pacific Vaccines For Children (VFC) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Vaccines For Children (VFC) Market Size by Type
9.1.1 Latin America Vaccines For Children (VFC) Sales by Type (2017-2028)
9.1.2 Latin America Vaccines For Children (VFC) Revenue by Type (2017-2028)
9.2 Latin America Vaccines For Children (VFC) Market Size by Application
9.2.1 Latin America Vaccines For Children (VFC) Sales by Application (2017-2028)
9.2.2 Latin America Vaccines For Children (VFC) Revenue by Application (2017-2028)
9.3 Latin America Vaccines For Children (VFC) Market Size by Country
9.3.1 Latin America Vaccines For Children (VFC) Sales by Country (2017-2028)
9.3.2 Latin America Vaccines For Children (VFC) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Vaccines For Children (VFC) Market Size by Type
10.1.1 Middle East and Africa Vaccines For Children (VFC) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Vaccines For Children (VFC) Revenue by Type (2017-2028)
10.2 Middle East and Africa Vaccines For Children (VFC) Market Size by Application
10.2.1 Middle East and Africa Vaccines For Children (VFC) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Vaccines For Children (VFC) Revenue by Application (2017-2028)
10.3 Middle East and Africa Vaccines For Children (VFC) Market Size by Country
10.3.1 Middle East and Africa Vaccines For Children (VFC) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Vaccines For Children (VFC) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Overview
11.1.3 GSK Vaccines For Children (VFC) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 GSK Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GSK Recent Developments
11.2 Sanofi
11.2.1 Sanofi Corporation Information
11.2.2 Sanofi Overview
11.2.3 Sanofi Vaccines For Children (VFC) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Sanofi Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sanofi Recent Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Overview
11.3.3 Merck Vaccines For Children (VFC) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Merck Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck Recent Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Vaccines For Children (VFC) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Pfizer Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer Recent Developments
11.5 Jintan
11.5.1 Jintan Corporation Information
11.5.2 Jintan Overview
11.5.3 Jintan Vaccines For Children (VFC) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Jintan Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Jintan Recent Developments
11.6 CSL
11.6.1 CSL Corporation Information
11.6.2 CSL Overview
11.6.3 CSL Vaccines For Children (VFC) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 CSL Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 CSL Recent Developments
11.7 MedImmune LLC
11.7.1 MedImmune LLC Corporation Information
11.7.2 MedImmune LLC Overview
11.7.3 MedImmune LLC Vaccines For Children (VFC) Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 MedImmune LLC Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 MedImmune LLC Recent Developments
11.8 J&J(Crucell)
11.8.1 J&J(Crucell) Corporation Information
11.8.2 J&J(Crucell) Overview
11.8.3 J&J(Crucell) Vaccines For Children (VFC) Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 J&J(Crucell) Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 J&J(Crucell) Recent Developments
11.9 China National Biotec
11.9.1 China National Biotec Corporation Information
11.9.2 China National Biotec Overview
11.9.3 China National Biotec Vaccines For Children (VFC) Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 China National Biotec Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 China National Biotec Recent Developments
11.10 Tiantan
11.10.1 Tiantan Corporation Information
11.10.2 Tiantan Overview
11.10.3 Tiantan Vaccines For Children (VFC) Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Tiantan Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Tiantan Recent Developments
11.11 Hualan
11.11.1 Hualan Corporation Information
11.11.2 Hualan Overview
11.11.3 Hualan Vaccines For Children (VFC) Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Hualan Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Hualan Recent Developments
11.12 Kangtai
11.12.1 Kangtai Corporation Information
11.12.2 Kangtai Overview
11.12.3 Kangtai Vaccines For Children (VFC) Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Kangtai Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Kangtai Recent Developments
11.13 Hissen
11.13.1 Hissen Corporation Information
11.13.2 Hissen Overview
11.13.3 Hissen Vaccines For Children (VFC) Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Hissen Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Hissen Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Vaccines For Children (VFC) Industry Chain Analysis
12.2 Vaccines For Children (VFC) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Vaccines For Children (VFC) Production Mode & Process
12.4 Vaccines For Children (VFC) Sales and Marketing
12.4.1 Vaccines For Children (VFC) Sales Channels
12.4.2 Vaccines For Children (VFC) Distributors
12.5 Vaccines For Children (VFC) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Vaccines For Children (VFC) Industry Trends
13.2 Vaccines For Children (VFC) Market Drivers
13.3 Vaccines For Children (VFC) Market Challenges
13.4 Vaccines For Children (VFC) Market Restraints
14 Key Findings in The Global Vaccines For Children (VFC) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Global Vaccines For Children (VFC) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Recombinant Vaccines
Table 3. Major Manufacturers of Viral Vaccines
Table 4. Major Manufacturers of Polysaccharide Vaccines
Table 5. Major Manufacturers of Others
Table 6. Global Vaccines For Children (VFC) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Vaccines For Children (VFC) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Vaccines For Children (VFC) Sales by Region (2017-2022) & (K Doses)
Table 9. Global Vaccines For Children (VFC) Sales Market Share by Region (2017-2022)
Table 10. Global Vaccines For Children (VFC) Sales by Region (2023-2028) & (K Doses)
Table 11. Global Vaccines For Children (VFC) Sales Market Share by Region (2023-2028)
Table 12. Global Vaccines For Children (VFC) Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Vaccines For Children (VFC) Revenue Market Share by Region (2017-2022)
Table 14. Global Vaccines For Children (VFC) Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Vaccines For Children (VFC) Revenue Market Share by Region (2023-2028)
Table 16. Global Vaccines For Children (VFC) Sales by Manufacturers (2017-2022) & (K Doses)
Table 17. Global Vaccines For Children (VFC) Sales Share by Manufacturers (2017-2022)
Table 18. Global Vaccines For Children (VFC) Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Vaccines For Children (VFC) Revenue Share by Manufacturers (2017-2022)
Table 20. Vaccines For Children (VFC) Price by Manufacturers (2017-2022) &(US$/Dose)
Table 21. Global Vaccines For Children (VFC) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Vaccines For Children (VFC) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccines For Children (VFC) as of 2021)
Table 23. Vaccines For Children (VFC) Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Vaccines For Children (VFC) Product Offered
Table 25. Date of Manufacturers Enter into Vaccines For Children (VFC) Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Vaccines For Children (VFC) Sales by Type (2017-2022) & (K Doses)
Table 28. Global Vaccines For Children (VFC) Sales by Type (2023-2028) & (K Doses)
Table 29. Global Vaccines For Children (VFC) Sales Share by Type (2017-2022)
Table 30. Global Vaccines For Children (VFC) Sales Share by Type (2023-2028)
Table 31. Global Vaccines For Children (VFC) Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Vaccines For Children (VFC) Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Vaccines For Children (VFC) Revenue Share by Type (2017-2022)
Table 34. Global Vaccines For Children (VFC) Revenue Share by Type (2023-2028)
Table 35. Vaccines For Children (VFC) Price by Type (2017-2022) & (US$/Dose)
Table 36. Global Vaccines For Children (VFC) Price Forecast by Type (2023-2028) & (US$/Dose)
Table 37. Global Vaccines For Children (VFC) Sales by Application (2017-2022) & (K Doses)
Table 38. Global Vaccines For Children (VFC) Sales by Application (2023-2028) & (K Doses)
Table 39. Global Vaccines For Children (VFC) Sales Share by Application (2017-2022)
Table 40. Global Vaccines For Children (VFC) Sales Share by Application (2023-2028)
Table 41. Global Vaccines For Children (VFC) Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Vaccines For Children (VFC) Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Vaccines For Children (VFC) Revenue Share by Application (2017-2022)
Table 44. Global Vaccines For Children (VFC) Revenue Share by Application (2023-2028)
Table 45. Vaccines For Children (VFC) Price by Application (2017-2022) & (US$/Dose)
Table 46. Global Vaccines For Children (VFC) Price Forecast by Application (2023-2028) & (US$/Dose)
Table 47. North America Vaccines For Children (VFC) Sales by Type (2017-2022) & (K Doses)
Table 48. North America Vaccines For Children (VFC) Sales by Type (2023-2028) & (K Doses)
Table 49. North America Vaccines For Children (VFC) Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Vaccines For Children (VFC) Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Vaccines For Children (VFC) Sales by Application (2017-2022) & (K Doses)
Table 52. North America Vaccines For Children (VFC) Sales by Application (2023-2028) & (K Doses)
Table 53. North America Vaccines For Children (VFC) Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Vaccines For Children (VFC) Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Vaccines For Children (VFC) Sales by Country (2017-2022) & (K Doses)
Table 56. North America Vaccines For Children (VFC) Sales by Country (2023-2028) & (K Doses)
Table 57. North America Vaccines For Children (VFC) Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Vaccines For Children (VFC) Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Vaccines For Children (VFC) Sales by Type (2017-2022) & (K Doses)
Table 60. Europe Vaccines For Children (VFC) Sales by Type (2023-2028) & (K Doses)
Table 61. Europe Vaccines For Children (VFC) Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Vaccines For Children (VFC) Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Vaccines For Children (VFC) Sales by Application (2017-2022) & (K Doses)
Table 64. Europe Vaccines For Children (VFC) Sales by Application (2023-2028) & (K Doses)
Table 65. Europe Vaccines For Children (VFC) Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Vaccines For Children (VFC) Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Vaccines For Children (VFC) Sales by Country (2017-2022) & (K Doses)
Table 68. Europe Vaccines For Children (VFC) Sales by Country (2023-2028) & (K Doses)
Table 69. Europe Vaccines For Children (VFC) Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Vaccines For Children (VFC) Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Vaccines For Children (VFC) Sales by Type (2017-2022) & (K Doses)
Table 72. Asia Pacific Vaccines For Children (VFC) Sales by Type (2023-2028) & (K Doses)
Table 73. Asia Pacific Vaccines For Children (VFC) Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Vaccines For Children (VFC) Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Vaccines For Children (VFC) Sales by Application (2017-2022) & (K Doses)
Table 76. Asia Pacific Vaccines For Children (VFC) Sales by Application (2023-2028) & (K Doses)
Table 77. Asia Pacific Vaccines For Children (VFC) Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Vaccines For Children (VFC) Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Vaccines For Children (VFC) Sales by Region (2017-2022) & (K Doses)
Table 80. Asia Pacific Vaccines For Children (VFC) Sales by Region (2023-2028) & (K Doses)
Table 81. Asia Pacific Vaccines For Children (VFC) Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Vaccines For Children (VFC) Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Vaccines For Children (VFC) Sales by Type (2017-2022) & (K Doses)
Table 84. Latin America Vaccines For Children (VFC) Sales by Type (2023-2028) & (K Doses)
Table 85. Latin America Vaccines For Children (VFC) Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Vaccines For Children (VFC) Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Vaccines For Children (VFC) Sales by Application (2017-2022) & (K Doses)
Table 88. Latin America Vaccines For Children (VFC) Sales by Application (2023-2028) & (K Doses)
Table 89. Latin America Vaccines For Children (VFC) Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Vaccines For Children (VFC) Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Vaccines For Children (VFC) Sales by Country (2017-2022) & (K Doses)
Table 92. Latin America Vaccines For Children (VFC) Sales by Country (2023-2028) & (K Doses)
Table 93. Latin America Vaccines For Children (VFC) Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Vaccines For Children (VFC) Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Vaccines For Children (VFC) Sales by Type (2017-2022) & (K Doses)
Table 96. Middle East and Africa Vaccines For Children (VFC) Sales by Type (2023-2028) & (K Doses)
Table 97. Middle East and Africa Vaccines For Children (VFC) Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Vaccines For Children (VFC) Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Vaccines For Children (VFC) Sales by Application (2017-2022) & (K Doses)
Table 100. Middle East and Africa Vaccines For Children (VFC) Sales by Application (2023-2028) & (K Doses)
Table 101. Middle East and Africa Vaccines For Children (VFC) Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Vaccines For Children (VFC) Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Vaccines For Children (VFC) Sales by Country (2017-2022) & (K Doses)
Table 104. Middle East and Africa Vaccines For Children (VFC) Sales by Country (2023-2028) & (K Doses)
Table 105. Middle East and Africa Vaccines For Children (VFC) Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Vaccines For Children (VFC) Revenue by Country (2023-2028) & (US$ Million)
Table 107. GSK Corporation Information
Table 108. GSK Description and Major Businesses
Table 109. GSK Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 110. GSK Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. GSK Recent Developments
Table 112. Sanofi Corporation Information
Table 113. Sanofi Description and Major Businesses
Table 114. Sanofi Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 115. Sanofi Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Sanofi Recent Developments
Table 117. Merck Corporation Information
Table 118. Merck Description and Major Businesses
Table 119. Merck Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 120. Merck Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Merck Recent Developments
Table 122. Pfizer Corporation Information
Table 123. Pfizer Description and Major Businesses
Table 124. Pfizer Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 125. Pfizer Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Pfizer Recent Developments
Table 127. Jintan Corporation Information
Table 128. Jintan Description and Major Businesses
Table 129. Jintan Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 130. Jintan Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Jintan Recent Developments
Table 132. CSL Corporation Information
Table 133. CSL Description and Major Businesses
Table 134. CSL Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 135. CSL Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. CSL Recent Developments
Table 137. MedImmune LLC Corporation Information
Table 138. MedImmune LLC Description and Major Businesses
Table 139. MedImmune LLC Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 140. MedImmune LLC Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. MedImmune LLC Recent Developments
Table 142. J&J(Crucell) Corporation Information
Table 143. J&J(Crucell) Description and Major Businesses
Table 144. J&J(Crucell) Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 145. J&J(Crucell) Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. J&J(Crucell) Recent Developments
Table 147. China National Biotec Corporation Information
Table 148. China National Biotec Description and Major Businesses
Table 149. China National Biotec Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 150. China National Biotec Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. China National Biotec Recent Developments
Table 152. Tiantan Corporation Information
Table 153. Tiantan Description and Major Businesses
Table 154. Tiantan Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 155. Tiantan Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Tiantan Recent Developments
Table 157. Hualan Corporation Information
Table 158. Hualan Description and Major Businesses
Table 159. Hualan Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 160. Hualan Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Hualan Recent Developments
Table 162. Kangtai Corporation Information
Table 163. Kangtai Description and Major Businesses
Table 164. Kangtai Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 165. Kangtai Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Kangtai Recent Developments
Table 167. Hissen Corporation Information
Table 168. Hissen Description and Major Businesses
Table 169. Hissen Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 170. Hissen Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Hissen Recent Developments
Table 172. Key Raw Materials Lists
Table 173. Raw Materials Key Suppliers Lists
Table 174. Vaccines For Children (VFC) Distributors List
Table 175. Vaccines For Children (VFC) Customers List
Table 176. Vaccines For Children (VFC) Market Trends
Table 177. Vaccines For Children (VFC) Market Drivers
Table 178. Vaccines For Children (VFC) Market Challenges
Table 179. Vaccines For Children (VFC) Market Restraints
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Vaccines For Children (VFC) Product Picture
Figure 3. Global Vaccines For Children (VFC) Market Share by Type in 2021 & 2028
Figure 3. Recombinant Vaccines Product Picture
Figure 4. Viral Vaccines Product Picture
Figure 5. Polysaccharide Vaccines Product Picture
Figure 6. Others Product Picture
Figure 7. Global Vaccines For Children (VFC) Market Share by Application in 2021 & 2028
Figure 8. Government Institution
Figure 9. Private Sector
Figure 10. Other
Figure 11. Vaccines For Children (VFC) Report Years Considered
Figure 12. Global Vaccines For Children (VFC) Sales 2017-2028 (K Doses)
Figure 13. Global Vaccines For Children (VFC) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Vaccines For Children (VFC) Revenue 2017-2028 (US$ Million)
Figure 15. Global Vaccines For Children (VFC) Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Vaccines For Children (VFC) Sales Market Share by Region (2017-2022)
Figure 17. Global Vaccines For Children (VFC) Sales Market Share by Region (2023-2028)
Figure 18. North America Vaccines For Children (VFC) Sales YoY (2017-2028) & (K Doses)
Figure 19. North America Vaccines For Children (VFC) Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Vaccines For Children (VFC) Sales YoY (2017-2028) & (K Doses)
Figure 21. Europe Vaccines For Children (VFC) Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Vaccines For Children (VFC) Sales YoY (2017-2028) & (K Doses)
Figure 23. Asia-Pacific Vaccines For Children (VFC) Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Vaccines For Children (VFC) Sales YoY (2017-2028) & (K Doses)
Figure 25. Latin America Vaccines For Children (VFC) Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Vaccines For Children (VFC) Sales YoY (2017-2028) & (K Doses)
Figure 27. Middle East & Africa Vaccines For Children (VFC) Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Vaccines For Children (VFC) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Vaccines For Children (VFC) in the World: Market Share by Vaccines For Children (VFC) Revenue in 2021
Figure 30. Global Vaccines For Children (VFC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Vaccines For Children (VFC) Sales Market Share by Type (2017-2028)
Figure 32. Global Vaccines For Children (VFC) Revenue Market Share by Type (2017-2028)
Figure 33. Global Vaccines For Children (VFC) Sales Market Share by Application (2017-2028)
Figure 34. Global Vaccines For Children (VFC) Revenue Market Share by Application (2017-2028)
Figure 35. North America Vaccines For Children (VFC) Sales Market Share by Type (2017-2028)
Figure 36. North America Vaccines For Children (VFC) Revenue Market Share by Type (2017-2028)
Figure 37. North America Vaccines For Children (VFC) Sales Market Share by Application (2017-2028)
Figure 38. North America Vaccines For Children (VFC) Revenue Market Share by Application (2017-2028)
Figure 39. North America Vaccines For Children (VFC) Sales Share by Country (2017-2028)
Figure 40. North America Vaccines For Children (VFC) Revenue Share by Country (2017-2028)
Figure 41. U.S. Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Vaccines For Children (VFC) Sales Market Share by Type (2017-2028)
Figure 44. Europe Vaccines For Children (VFC) Revenue Market Share by Type (2017-2028)
Figure 45. Europe Vaccines For Children (VFC) Sales Market Share by Application (2017-2028)
Figure 46. Europe Vaccines For Children (VFC) Revenue Market Share by Application (2017-2028)
Figure 47. Europe Vaccines For Children (VFC) Sales Share by Country (2017-2028)
Figure 48. Europe Vaccines For Children (VFC) Revenue Share by Country (2017-2028)
Figure 49. Germany Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
Figure 50. France Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Vaccines For Children (VFC) Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Vaccines For Children (VFC) Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Vaccines For Children (VFC) Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Vaccines For Children (VFC) Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Vaccines For Children (VFC) Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Vaccines For Children (VFC) Revenue Share by Region (2017-2028)
Figure 60. China Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
Figure 63. India Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
Figure 65. Taiwan Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
Figure 69. Philippines Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America Vaccines For Children (VFC) Sales Market Share by Type (2017-2028)
Figure 71. Latin America Vaccines For Children (VFC) Revenue Market Share by Type (2017-2028)
Figure 72. Latin America Vaccines For Children (VFC) Sales Market Share by Application (2017-2028)
Figure 73. Latin America Vaccines For Children (VFC) Revenue Market Share by Application (2017-2028)
Figure 74. Latin America Vaccines For Children (VFC) Sales Share by Country (2017-2028)
Figure 75. Latin America Vaccines For Children (VFC) Revenue Share by Country (2017-2028)
Figure 76. Mexico Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
Figure 77. Brazil Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
Figure 78. Argentina Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa Vaccines For Children (VFC) Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Vaccines For Children (VFC) Revenue Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Vaccines For Children (VFC) Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Vaccines For Children (VFC) Revenue Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Vaccines For Children (VFC) Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa Vaccines For Children (VFC) Revenue Share by Country (2017-2028)
Figure 85. Turkey Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
Figure 87. UAE Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
Figure 88. Vaccines For Children (VFC) Value Chain
Figure 89. Vaccines For Children (VFC) Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed
